Search

Your search keyword '"Guardigli G"' showing total 139 results

Search Constraints

Start Over You searched for: Author "Guardigli G" Remove constraint Author: "Guardigli G"
139 results on '"Guardigli G"'

Search Results

54. A New Single Lead VDD Pacing System

57. Analysis of azide-insensitive Ca2+-dependent ATPase activity in atrial specimens from patients with coronary or valvular heart disease

63. Induction of hormesis in plants by urban trace metal pollution

64. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation. the GLORIA-AF registry

65. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

66. A COVID-19 specific multiparametric and ECG-based score for the prediction of in-hospital mortality: ELCOVID score.

67. Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge.

68. Safety and efficacy of new-generation coronary bioresorbable scaffolds.

69. [Epicardial adipose tissue: a novel cardiovascular risk factor].

70. Cardiovascular prevention: sometimes dreams can come true.

71. Cardiovascular prevention: sometimes dreams can come true.

72. The future of cardiovascular prevention: between fiction and reality.

73. Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study.

75. [Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region].

76. Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome.

77. Induction of hormesis in plants by urban trace metal pollution.

78. In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study.

79. Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement.

80. [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts].

83. Reperfusion Damage - A Story of Success, Failure, and Hope.

84. Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.

85. A modern fairy tale.

86. [Beyond dyssynchrony: what are the factors determining the response to cardiac resynchronization therapy?].

87. Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients.

88. Tirofiban: a critical reappraisal of the clinical use, recent developments and future perspectives.

89. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].

91. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.

92. The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial.

93. Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders.

94. High-dose bolus tirofiban and sirolimus eluting stent versus abiciximab and bare metal stent in acute myocardial infarction (STRATEGY) study--protocol design and demography of the first 100 patients.

95. Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction.

96. Clinical feasibility of low energy internal atrial cardioversion with a three-electrode configuration in patients with unsuccessful conventional configurations.

97. AV delay optimization and management of DDD paced patients with dilated cardiomyopathy.

98. Long-term reliability of single lead atrial synchronous pacing systems using closely spaced atrial dipoles: five-year experience.

99. Direct and autonomically mediated effects of oral quinidine on RR/QT relation after an abrupt increase in heart rate.

100. Changes in prostaglandin renal synthesis in cardiovascular disease.

Catalog

Books, media, physical & digital resources